Tafamidis is a selective transthyretin stabilizer used as a medication to treat both hereditary and wild-type transthyretin-mediated amyloidosis. Pharmaceutical laboratories require access to this parent… Read more
![Chemical structure of 2'-(3,5-Dichlorophenyl)-[2,6'-bibenzo[d]oxazole]-6-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-35-Dichlorophenyl-26-bibenzodoxazole-6-carboxylic-Acid.png&w=3840&q=75)

![Chemical structure of 2-(3,5-Dichlorophenyl)-N,N-dimethylbenzo[d]oxazole-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2892700-63-7-2-35-Dichlorophenyl-NN-dimethylbenzodoxazole-6-carboxamide.png&w=3840&q=75)
![Chemical structure of 2-(3,5-Dichlorophenyl)-N-methyl-N-((2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl)benzo[d]oxazole-6-carboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-35-Dichlorophenyl-N-methyl-N-2S3R4R5R-23456-pentahydroxyhexylbenzodoxazole-6-carboxamide.png&w=3840&q=75)
![Chemical structure of 2-(3-Chlorophenyl)benzo[d]oxazole-6-carboxylic Acid;](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1521571-08-3-2-3-Chlorophenylbenzodoxazole-6-carboxylic-Acid.png&w=3840&q=75)





![Chemical structure of 4-[(3,5-Dichlorobenzoyl)amino]-3-hydroxybenzoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1184581-58-5-4-35-Dichlorobenzoylamino-3-hydroxybenzoic-Acid.png&w=3840&q=75)
![Chemical structure of 7-Chloro-2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7-Chloro-2-35-dichlorophenylbenzodoxazole-6-carboxylic-Acid.png&w=3840&q=75)

![Chemical structure of Ethyl 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2395012-64-1-Ethyl-2-35-dichlorophenylbenzodoxazole-6-carboxylate.png&w=3840&q=75)
![Chemical structure of Isopropyl 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2564746-65-0-Isopropyl-2-35-dichlorophenylbenzodoxazole-6-carboxylate.png&w=3840&q=75)

![Chemical structure of Methyl 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1395964-06-3-Methyl-2-35-dichlorophenylbenzodoxazole-6-carboxylate.png&w=3840&q=75)


















Tafamidis is a selective transthyretin stabilizer used as a medication to treat both hereditary and wild-type transthyretin-mediated amyloidosis. Pharmaceutical laboratories require access to this parent drug and its related compounds to ensure accurate analytical testing, method validation, and quality control throughout the drug development and manufacturing lifecycle. This category contains a comprehensive range of reference standards, including identified impurities, major metabolites such as the acyl glucuronide, and stable isotope labelled compounds. These materials are essential for precise impurity profiling and quantitative analysis, enabling researchers to maintain strict compliance with regulatory standards. By utilizing high-quality reference materials, laboratories can reliably identify, quantify, and characterize potential degradants and metabolic products associated with this therapeutic agent.